ABT vs. RMD: Abbott Laboratories vs. ResMed Stock Comparison

November 11, 2026

How do Abbott Laboratories (ABT) and ResMed (RMD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Abbott Laboratories (ABT) and ResMed (RMD) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Company profile comparison for Abbott Laboratories (ABT) and ResMed (RMD)
Profile Item	ABT	RMD
Name	Abbott Laboratories	ResMed Inc.
Country/Region	United States	United States
GICS Sector	Health Care	Health Care
GICS Industry Group	Health Care Equipment & Services	Health Care Equipment & Services
GICS Industry	Health Care Equipment & Supplies	Health Care Equipment & Supplies
GICS Sub-Industry	Health Care Equipment	Health Care Equipment
Market Capitalization	190.39 billion USD	33.10 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	March 17, 1980	June 2, 1995
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

ABT

RMD

GSPC

Abbott Laboratories (ABT) vs. ResMed (RMD), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Abbott Laboratories (ABT) and ResMed (RMD). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Abbott Laboratories (ABT) and ResMed (RMD). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Abbott Laboratories (ABT) and ResMed (RMD)
Metric	ABT	RMD
Total Return (1Y)	-10.78%	-5.42%
Total Return (3Y, Annualized)	7.79%	18.99%
Total Return (5Y, Annualized)	-0.79%	-1.23%

Risk Profile

Drawdown History

ABT

RMD

GSPC

Abbott Laboratories (ABT) vs. ResMed (RMD), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Abbott Laboratories (ABT) and ResMed (RMD). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Abbott Laboratories (ABT) and ResMed (RMD)
Metric	ABT	RMD
Volatility (1Y, Annualized)	28.48%	30.80%
Beta (5Y)	0.53	0.75
Max Drawdown (5Y)	-39.64%	-49.04%
Avg. Volume (3M)	8.74M	1.32M

Risk-Adjusted Performance

Risk-Return Positioning

ABT and RMD are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Abbott Laboratories (ABT) and ResMed (RMD)
Metric	ABT	RMD
Sharpe Ratio (1Y)	-0.53	-0.31
Sortino Ratio (1Y)	-0.76	-0.43

Profitability

ROE (TTM)

ResMed (RMD) at 26.40% sits in the top ROE quartile, while Abbott Laboratories (ABT) at 9.14% is closer to the peer norm — stronger capital efficiency for RMD.

ABT

Health Care Equipment & Services industry group

9.14%

Max: 47.61%
Q3: 14.36%
ABT: 9.14%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

RMD

Health Care Equipment & Services industry group

26.40%

Max: 47.61%
RMD: 26.40%
Q3: 14.36%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

For every dollar of sales, both Abbott Laboratories (ABT) at 9.75% and ResMed (RMD) at 27.79% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

ABT

Health Care Equipment & Services industry group

9.75%

Max: 29.35%
ABT: 9.75%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

RMD

Health Care Equipment & Services industry group

27.79%

Max: 29.35%
RMD: 27.79%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

ResMed (RMD) at 34.82% operates in the top operating margin quartile, ahead of Abbott Laboratories (ABT) at 11.66%, which runs around its industry’s norm.

ABT

Health Care Equipment & Services industry group

11.66%

Max: 35.43%
Q3: 14.14%
ABT: 11.66%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

RMD

Health Care Equipment & Services industry group

34.82%

Max: 35.43%
RMD: 34.82%
Q3: 14.14%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for Abbott Laboratories (ABT) and ResMed (RMD)
Metric	ABT	RMD
ROE (TTM)	9.14%	26.40%
ROA (TTM)	4.90%	14.76%
Net Margin (TTM)	9.75%	27.79%
Operating Margin (TTM)	11.66%	34.82%
Gross Margin (TTM)	57.17%	61.77%

Growth

Revenue Growth

Both Abbott Laboratories (ABT) at 5.67% and ResMed (RMD) at 9.85% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their Revenue Growth across different time periods.

EPS Growth

Only one side can be read here: Abbott Laboratories (ABT) reports EPS growth of -51.31%, ranked against its industry; ResMed (RMD) has no EPS growth figure this period.

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Abbott Laboratories (ABT) and ResMed (RMD)
Metric	ABT	RMD
Revenue Growth (YoY)	5.67%	9.85%
Revenue Growth (3Y CAGR)	0.51%	10.21%
EPS Growth (YoY)	-51.31%	--
EPS Growth (3Y CAGR)	-1.65%	19.64%

Financial Strength

Current Ratio (MRQ)

Both Abbott Laboratories (ABT) at 1.46 and ResMed (RMD) at 2.65 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

ABT

Health Care Equipment & Services industry group

1.46

Max: 7.59
Q3: 4.00
Median: 1.98
ABT: 1.46
Q1: 1.37
Min: 0.30

RMD

Health Care Equipment & Services industry group

2.65

Max: 7.59
Q3: 4.00
RMD: 2.65
Median: 1.98
Q1: 1.37
Min: 0.30

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

ResMed (RMD) at 0.10 keeps leverage in the lower industry quartile, while Abbott Laboratories (ABT) at 0.61 runs a more typical debt-to-equity mix.

ABT

Health Care Equipment & Services industry group

0.61

Max: 1.88
Q3: 0.91
ABT: 0.61
Median: 0.58
Q1: 0.16
Min: 0.00

RMD

Health Care Equipment & Services industry group

0.10

Max: 1.88
Q3: 0.91
Median: 0.58
Q1: 0.16
RMD: 0.10
Min: 0.00

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Abbott Laboratories (ABT) and ResMed (RMD)
Metric	ABT	RMD
Current Ratio (MRQ)	1.46	2.65
Debt / Equity (MRQ)	0.61	0.10
Net Debt / EBITDA	2.37	-0.19

Dividends

Dividend Yield (TTM)

Both Abbott Laboratories (ABT) at 2.22% and ResMed (RMD) at 1.03% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

ABT

Health Care Equipment & Services industry group

2.22%

ABT: 2.22%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

RMD

Health Care Equipment & Services industry group

1.03%

RMD: 1.03%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

Both Abbott Laboratories (ABT) at 92.54% and ResMed (RMD) at 22.40% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.

ABT

Health Care Equipment & Services industry group

92.54%

ABT: 92.54%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

RMD

Health Care Equipment & Services industry group

22.40%

RMD: 22.40%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for Abbott Laboratories (ABT) and ResMed (RMD)
Metric	ABT	RMD
Dividend Yield (TTM)	2.22%	1.03%
Dividend Payout Ratio (TTM)	92.54%	22.40%

Valuation

P/E Ratio (TTM)

Both Abbott Laboratories (ABT) at 41.02 and ResMed (RMD) at 21.43 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

ABT

Health Care Equipment & Services industry group

41.02

Max: 80.41
Q3: 47.62
ABT: 41.02
Median: 29.93
Q1: 21.19
Min: 4.21

RMD

Health Care Equipment & Services industry group

21.43

Max: 80.41
Q3: 47.62
Median: 29.93
RMD: 21.43
Q1: 21.19
Min: 4.21

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their P/E ratio against the Health Care Equipment & Services industry group benchmark.

P/S Ratio (TTM)

Abbott Laboratories (ABT) at 3.95 is priced about in line with its industry on P/S ratio, while ResMed (RMD) at 5.77 sits in the pricier quartile — RMD costs more per dollar of sales.

ABT

Health Care Equipment & Services industry group

3.95

Max: 8.80
Q3: 4.32
ABT: 3.95
Median: 2.13
Q1: 1.10
Min: 0.03

RMD

Health Care Equipment & Services industry group

5.77

Max: 8.80
RMD: 5.77
Q3: 4.32
Median: 2.13
Q1: 1.10
Min: 0.03

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

On P/B ratio, both Abbott Laboratories (ABT) at 3.73 and ResMed (RMD) at 5.56 are valued close to their industries’ norm against book — neither stands out from peers.

ABT

Health Care Equipment & Services industry group

3.73

Max: 11.68
Q3: 6.12
ABT: 3.73
Median: 3.00
Q1: 1.73
Min: -1.31

RMD

Health Care Equipment & Services industry group

5.56

Max: 11.68
Q3: 6.12
RMD: 5.56
Median: 3.00
Q1: 1.73
Min: -1.31

Abbott Laboratories (ABT) vs. ResMed (RMD): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for Abbott Laboratories (ABT) and ResMed (RMD)
Metric	ABT	RMD
P/E Ratio (TTM)	41.02	21.43
P/S Ratio (TTM)	3.95	5.77
P/B Ratio (MRQ)	3.73	5.56
Free Cash Flow Yield (TTM)	3.19%	3.92%